Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 2Lymphoma 2Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Philadelphia Chromosome 1Neuroendocrine Tumors 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Leukemia, B-Cell 1Leukemia 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1Advanced Solid Tumors 1

Interventions

ofatumumab 10Cyclophosphamide 6fludarabine 5ibrutinib 4fludarabine phosphate 4Bortezomib 3Tablets 2Chlorambucil 2tirabrutinib 1pegaspargase 1nelarabine 1immunotoxin HA22 1bempegaldesleukin 1Whole-Body Irradiation 1Vincristine 1Panobinostat 1Observation 1Nivolumab 1Mitoxantrone 1Methotrexate 1Mesna 1Mercaptopurine 1Magnetic Resonance Imaging 1MLN 8237 1Lenalidomide 1KW-2478 1Hsp90 inhibitor KU757 1Etoposide 1Electrocardiography 1Echocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, B-Cell × Antiemetics × Clear all
NCT03448393 2025-06-04

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
54 enrolled 24 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Philadelphia Chromosome, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡